Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies].

Deutsche medizinische Wochenschrift (1946) - 1 Feb 2020

Keitel Verena, Vom Dahl Stephan, Häussinger Dieter

Abstract excerpt

Secondary causes of fatty liver disease are important to recognize since specific therapy options are available for some of these causes. Common causes of secondary fatty liver disease comprise hepatitis C virus infection (HCV), endocrinological diseases, nutritional and intestinal diseases as well as genetic liver and metabolic diseases. Certain drugs may also predispose to the development of fatty liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatty Liver
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Hypothyroidism

Share to Metabolic Syndrome

Source

Identifiers

PMID: 32018285
DOI: 10.1055/a-0965-9648

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies].PMID 32018285Read ↗

Diagnosis and management of secondary causes of steatohepatitis.Semantic proximity Read ↗

[Pathogenesis of non-alcoholic fatty liver disease].Semantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Non-alcoholic fatty liver disease pathogenesis: the present and the future.Semantic proximity Read ↗

An overview of the genetics, mechanisms and management of NAFLD and ALDSemantic proximity Read ↗

Fatty Liver Disease: A Global Silent EpidemicSemantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Nonalcoholic fatty liver disease.Semantic proximity Read ↗

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment conceptsSemantic proximity Read ↗

NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.Semantic proximity Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.